Diagnostic Value of UTB and TB for PPL

NCT04571476 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 578

Last updated 2023-09-06

No results posted yet for this study

Summary

The purpose of the study is to evaluate the diagnostic value and safety of ultrathin and thin bronchoscope (UTB and TB) for peripheral pulmonary lesions (PPLs) without X-ray fluoroscopy.

Conditions

  • Peripheral Pulmonary Lesion

Interventions

PROCEDURE

Ultrathin bronchoscope

Ultrathin bronchoscope (UTB) with an outer diameter no more than 3.0-mm and a 1.7-mm working channel.

PROCEDURE

Thin bronchoscope

Thin bronchoscope with a 4.0-mm outer diameter and a 2.0-mm working channel.

PROCEDURE

Virtual bronchoscopic navigation combined with endobronchial ultrasound

VBN can create a path to the target lesion automatically when the lesion is depicted in this software.VBN combined with EBUS can improve the diagnostic yield of PPL and shorten the examination time, which has become the standard method for the diagnosis of PPL.

PROCEDURE

Guide sheath

GS is a cannula with the thinnest outer diameter of 1.95 mm.

Sponsors & Collaborators

  • The First Affiliated Hospital of Guangzhou Medical University

    collaborator OTHER
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    collaborator OTHER
  • West China Hospital

    collaborator OTHER
  • Henan Provincial People's Hospital

    collaborator OTHER
  • Shanghai Chest Hospital

    lead OTHER

Principal Investigators

  • Jiayuan Sun, MD, PhD · Shanghai Chest Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-08
Primary Completion
2022-01-07
Completion
2022-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04571476 on ClinicalTrials.gov